"Silent" tyrosinemia presenting as hepatocellular carcinoma in a 10-year-old girl

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 3, 2007, Pages 375-377

  Castilloux, Julie ^a   Laberge, Anne Marie ^a,b   Martin, Steven R ^a   Lallier, Michel ^a   Marchand, Valérie ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; GALLIUM 67; SULFUR; ANTINEOPLASTIC AGENT;

ABDOMINAL RADIOGRAPHY; ABDOMINAL SCINTISCANNING; ARTICLE; ASCITES; CANCER PALLIATIVE THERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER NODULE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCHOOL CHILD; SPLENOMEGALY; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TYROSINEMIA; CHILD; LIVER TUMOR; PALLIATIVE THERAPY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHILD; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; PALLIATIVE CARE; TYROSINEMIAS;

EID: 33847733853     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31802f640c     Document Type: Article

References (16)

1. Darbari A, Sabin KM, Shapiro CN, et al. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003;38:560-6.
2. Yu SB, Kim HY, Eo H, et al. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma. World J Surg 2006;30:43-50.
3. Czauderna P. Adult type vs. childhood hepatocellular carcinoma: are they the same or different lesions? Biology, natural history, prognosis, and treatment. Med Pediatr Oncol 2002;39:519-23.
4. Czauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002;20:2798-804.
5. van Spronsen FJ, Bijleveld CM, van Maldegem BT, et al. Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro-methylbenzoyl)-1,3-cyclohexanedione treatment. J Pediatr Gastroenterol Nutr 2005;40:90-3.
6. Esquivel CO, Gutierrez C, Cox KL, et al. Hepatocellular carcinoma and liver cell dysplasia in children with chronic liver disease. J Pediatr Surg 1994;29:1465-9.
7. Superina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996;31:835-9.
8. Moore SW, Millar AJ, Hadley GP, et al. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence. Cancer 2004;101:642-9.
9. Emre S, McKenna GJ. Liver tumors in children. Pediatr Transplant 2004;8:632-8.
10. Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis 2001;21:563-71.
11. Scott CR. The genetic tyrosinemias. Am J Med Genet C Semin Med Genet 2006;142:121-6.
12. Laberge AM, Michaud J, Richter A, et al. Population history and its impact on medical genetics in Quebec. Clin Genet 2005;68:287-301.
13. Russo PA, Mitchell GA, Tanguay RM. Tyrosinemia: a review. Pediatr Dev Pathol 2001;4:212-21.
14. Mitchell G, Larochelle J, Lambert M, et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med 1990;322:432-7.
15. Kim SZ, Kupke KG, Ierardi-Curto L, et al. Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I. J Inherit Metab Dis 2000;23:791-804.
16. Sovik O, Kvittingen EA, Steen-Johnsen J, et al. Hereditary tyrosinemia of chronic course without rickets and renal tubular dysfunction. Acta Paediatr Scand 1990;79:1063-8.